Alexander J Denner Ironwood Pharmaceuticals Inc (IRWD) insider trading activity

Alexander J Denner is of IRONWOOD PHARMACEUTICALS INC. Currently has a direct ownership of 156,353 shares of IRWD, which is worth approximately $684,826. The most recent transaction as insider was on Dec 16, 2024, when has been sold 4,249 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 156K

2.79% 3M change

29.99% 12M change

Total Value Held $684,826

ALEXANDER J DENNER Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 16 2024	BUY Grant, award, or other acquisition	-	4,249 Added 2.65%	156,353 Class A Common Stock
Sep 16 2024	BUY Grant, award, or other acquisition	-	3,282 Added 2.11%	152,104 Class A Common Stock
Jun 18 2024	BUY Grant, award, or other acquisition	-	24,311 Added 14.04%	148,822 Class A Common Stock
Jun 15 2024	BUY Grant, award, or other acquisition	-	2,572 Added 2.02%	124,511 Class A Common Stock
Mar 15 2024	BUY Grant, award, or other acquisition	-	1,662 Added 1.34%	121,939 Class A Common Stock
Dec 15 2023	BUY Grant, award, or other acquisition	-	1,347 Added 1.11%	120,277 Class A Common Stock
Sep 15 2023	BUY Grant, award, or other acquisition	-	1,798 Added 1.49%	118,930 Class A Common Stock
Jun 20 2023	BUY Grant, award, or other acquisition	-	22,350 Added 16.02%	117,132 Class A Common Stock
Jun 15 2023	BUY Grant, award, or other acquisition	-	1,359 Added 1.41%	94,782 Class A Common Stock
Mar 15 2023	BUY Grant, award, or other acquisition	-	1,438 Added 1.52%	93,423 Class A Common Stock
Dec 15 2022	BUY Grant, award, or other acquisition	-	1,244 Added 1.33%	91,985 Class A Common Stock
Sep 15 2022	BUY Grant, award, or other acquisition	-	1,374 Added 1.49%	90,741 Class A Common Stock
Jun 15 2022	BUY Grant, award, or other acquisition	-	1,222 Added 1.35%	89,367 Class A Common Stock
Jun 01 2022	BUY Grant, award, or other acquisition	-	21,571 Added 19.66%	88,145 Class A Common Stock
Mar 15 2022	BUY Grant, award, or other acquisition	-	1,152 Added 1.7%	66,574 Class A Common Stock
Dec 15 2021	BUY Grant, award, or other acquisition	-	1,211 Added 1.82%	65,422 Class A Common Stock
Sep 15 2021	BUY Grant, award, or other acquisition	-	1,137 Added 1.74%	64,211 Class A Common Stock
Jun 15 2021	BUY Grant, award, or other acquisition	-	1,229 Added 1.91%	63,074 Class A Common Stock
Jun 02 2021	BUY Grant, award, or other acquisition	-	22,766 Added 26.91%	61,845 Class A Common Stock
Mar 15 2021	BUY Grant, award, or other acquisition	-	1,235 Added 3.06%	39,079 Class A Common Stock
Dec 15 2020	BUY Grant, award, or other acquisition	-	661 Added 1.72%	37,844 Class A Common Stock
Nov 09 2020	BUY Grant, award, or other acquisition	-	37,183 Added 50.0%	37,183 Class A Common Stock

Also insider at

SEEL

SEELOS THERAPEUTICS, INC. Healthcare

> 10% Shareholder

RGLS

Regulus Therapeutics Inc. Healthcare

> 10% Shareholder

ITRM

Iterum Therapeutics plc Healthcare

> 10% Shareholder

BIIB

BIOGEN INC. Healthcare

Director

INVA

Innoviva, Inc. Healthcare

AJD